Jeremy Barton, M.D. has served as our Chief Medical Officer since August 2016. Prior to joining eFFECTOR, Dr. Barton was the Vice President Head of Oncology, Biotechnology Clinical Development at Pfizer Inc. since July 2011, where he led a team of medical doctors, scientists and statisticians responsible for clinical development of an early oncology portfolio. Additionally, while at Pfizer, Dr. Barton served as chair of the Oncology Technical Review Committee and as co-chair of the Oncology Research Strategic Review Board. Previously, Dr. Barton served as the Vice President and Chief Medical Officer, Oncology of Biogen Idec, a biotechnology company, and was a Senior Medical Director at Seattle Genetics, Inc., a biotechnology company. Dr. Barton received his medical degree from University College Hospital Medical School, London and a Masters in Physiological Sciences from Oxford University.